Literature DB >> 7264301

The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance.

R Hunter, F Strickland, F Kézdy.   

Abstract

We developed an experimental model for studying the physicochemical basis of the adjuvant activity of surface-active agents. Pluronic polyols are chemically similar but physicochemically diverse surface-active agents composed of polymers of hydrophilic polyoxyethylene and lipophilic polyoxypropylene. One of them, L121, was found to be a powerful adjuvant for increasing antibody formation to BSA in mice when injected in an oil-in-water emulsion. Another, L101, was less effective in increasing antibody formation, but was more effective in inducing granulomatous inflammation. Three others had little effect on either response. The ability of these and other surface active agents to serve as adjuvants correlated with a physicochemical parameter, the hydrophile-lipophile balance (HLB). All of the surfactants with strong adjuvant activity have HLB values of less than 2. They are strongly lipophilic and promote the retention of macromolecules by oil drops in oil-in-water emulsions. We propose that the adjuvant activity of these compounds is dependent on their ability to concentrate the adjuvant, immunogen, and host proteins on hydrophobic surfaces, where they are more effectively presented to cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Sterile filtration of a parenteral emulsion.

Authors:  D M Lidgate; T Trattner; R M Shultz; R Maskiewicz
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin.

Authors:  J M Brewer; J Alexander
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

3.  Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.

Authors:  Chengji Cui; Vernon C Stevens; Steven P Schwendeman
Journal:  Vaccine       Date:  2006-08-17       Impact factor: 3.641

4.  Antibody affinity maturation: the role of CD8+ cells.

Authors:  G P Holland; M W Steward
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

5.  Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.

Authors:  G J Zigterman; H Snippe; M Jansze; E B Ernste; M J De Reuver; J M Willers
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Authors:  Neeta Jain-Gupta; Araceli Contreras-Rodriguez; Ramesh Vemulapalli; Sharon G Witonsky; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  FEMS Immunol Med Microbiol       Date:  2012-12

7.  Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.

Authors:  D M Lidgate; R C Fu; N E Byars; L C Foster; J S Fleitman
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

Review 8.  TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.

Authors:  Robert L Hunter; Lisa Armitige; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

9.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

Authors:  M F Powell; L C Foster; A R Becker; W Lee
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

10.  Synthetic sulpholipopolysaccharides: novel adjuvants for humoral immune responses.

Authors:  L A Hilgers; H Snippe; M Jansze; J M Willers
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.